Omicron: A Beginning Understanding?
Key Points In today’s Recommendations for Industry, we discuss Omicron and what is beginning to be understood. Read more below. The CDC is currently recommending
Category: Communicable Disease
Omicron Detected; Biden to Announce New COVID Protections
Key Points In today’s Recommendations for Industry, we discuss the detection of Omicron in the U.S. and the White House announcement of new COVID protections.
‘Tis the Season…
Key Points In today’s Recommendations for Industry, we discuss current seasonal illnesses and what businesses should be doing. Read more below. Yesterday, with the increased
Exclusive TAG Update: Yes, Omicron Has Spread, but NOT a Cause for Panic
Exclusive TAG Update: Yes, Omicron Has Spread, but NOT a Cause for Panic The omicron variant of COVID-19, which was first identified in South Africa,
Triad of Trends Compels Double-Down on Symptom Monitoring
Key Points In today’s Recommendations for Industry, we emphasize the importance of monitoring symptoms as the rise of COVID-19, flu, or other respiratory illnesses begins
Climate Change Impacts on Food Safety
With the worldwide changes in weather patterns, along with the associated increases in temperature and extreme weather events, climate change and its variability are becoming
TAG Responds to Employer’s Questions on the ETS
Key Points In today’s Recommendations for Industry, we respond to employer questions on the OSHA ETS. Read more below. The Sixth Circuit Court of Appeals,
Businesses Likely Not Held to OSHA ETS Deadlines: A Legal Opinion
Key Points In today’s Recommendations for Industry, we discuss the legal opinion from the Littler law firm that businesses will likely not be held to
U.S. COVID Case Rate Descent Hits Plateau
Key Points In today’s Recommendations for Industry, we discuss TAG’s weekly matrix, the plateauing of case rates, and what businesses need to be doing. Read
OSHA ETS Temporarily Stayed…and Other COVID News
Key Points In today’s Recommendations for Industry, we discuss the stay of the OSHA ETS, the Pfizer antiviral, and a Science vaccine efficacy study. Read